Philip Morris International (NYSE:PM) is urging the U.S. Food and Drug Administration to allow the company to continue marketing its heated tobacco products in the U.S. as a “modified risk tobacco ...

Philip Morris International operated outside the U.S. for years, but has entered the market with smoke-free products. Sales of Iqos Iluma in the United States could be a game changer once approved.

April 30 (Reuters) - The U.S. Food and Drug Administration on Tuesday said it would allow Philip Morris to sell a heated tobacco product called IQOS in the United States, a major victory for the ...

Philip Morris International’s PM smoke-free business is gaining scale, and the performance of its flagship products, IQOS and ZYN, is central to this trajectory. In the second quarter of 2025, the ...

Fisher Asset Management holds $2.82 million worth of Philip Morris International Inc. (NYSE:PM) shares, helping it secure a place on our list of billionaire Ken Fisher’s 10 consumer stock picks with ...

Stifel analyst Matthew E. Smith reiterated a Buy rating on Philip Morris International Inc (NYSE:PM), raising the price forecast to $145 from $138. Yesterday, the Marlboro maker reported third-quarter ...

Altria Group, Inc. (MO) and Philip Morris International Inc. (PM) rank among the most influential players in the global ...